Abstract
Surgical resection for hepatocellular carcinoma is a safe treatment if proper selection criteria and state-of-the-art surgical techniques are applied. In surgical candidates with the same Child–Pugh classification, long-term outcome after resection depends on the presence of portal hypertension and multifocality of the tumor. Best outcomes are achieved in patients with a single hepatocellular carcinoma and no portal hypertension, the presence of which can be accurately established by hepatic vein catheterization or indirectly inferred by findings such as low platelet count, splenomegaly and esophageal varices. Patients with multiple hepatocellular carcinoma and/or portal hypertension have, by contrast, a significantly lower survival rate. Results from the study by Ishizawa et al. carried out in a Japanese institution ultimately validate Western studies. East and West can now share criteria to select the best candidates for surgery, and consider for the nonoptimal cases those other options that might offer better outcomes (transplantation) or similar outcomes to surgery with lower invasiveness and cost (ablation).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Bruix J et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35: 421–430
Bruix J and Sherman M (2005) Management of hepatocellular carcinoma. Hepatology 42: 1208–1236
Mazzaferro V et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693–699
Livraghi T et al. (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: is resection still the treatment of choice? Hepatology 47: 82–89
Beaugrand M et al. (2005) Local/regional and systemic treatments of hepatocellular carcinoma. Semin Liver Dis 25: 201–211
Ishizawa T et al. (2008) Neither multiple tumors nor portal hypertension are operative contraindications for hepatocellular carcinoma. Gastroenterology 134: 1908–1916
Llovet JM et al. (1999) Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30: 1434–1440
Varela M et al. (2007) Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46: 474–481
Acknowledgements
CIBEREHD is funded by the Instituto de Salud Carlos III.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Forner, A., Bruix, J. East meets the West—portal pressure predicts outcome of surgical resection for hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 6, 14–15 (2009). https://doi.org/10.1038/ncpgasthep1300
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpgasthep1300
This article is cited by
-
The clinical use of HVPG measurements in chronic liver disease
Nature Reviews Gastroenterology & Hepatology (2009)